Alps Advisors Inc Siga Technologies Inc Transaction History

Alps Advisors Inc

$17.8 Billion
Q3 2025

A detailed history of Alps Advisors Inc transactions in Siga Technologies Inc stock. As of the latest transaction made, Alps Advisors Inc holds 51,120 shares of SIGA stock, worth $306,720. This represents 0.0% of its overall portfolio holdings.

Number of Shares

51,120

Holding current value

$306,720

% of portfolio

0.0%

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 05, 2025	BUY	$6.46 - $9.48 $330,235 - $484,617	51,120 New	51,120 $467,000
Q4 2024 Feb 13, 2025	SELL	$5.73 - $7.72 $2,865 - $3,860	-500 Reduced 1.12%	44,250 $265,000
Q3 2024 Nov 12, 2024	BUY	$6.74 - $11.97 $301,615 - $535,657	44,750 New	44,750 $301,000
Q4 2022 Feb 14, 2023	BUY	$7.29 - $10.14 $575 - $801	79 Added 0.33%	23,838 $175,000
Q3 2022 Nov 14, 2022	BUY	$10.02 - $26.15 $238,065 - $621,297	23,759 New	23,759 $245,000
Q3 2019 Nov 04, 2019	SELL	$4.93 - $5.8 $306,345 - $360,406	-62,139 Closed	0 $0
Q2 2019 Aug 07, 2019	SELL	$5.22 - $6.1 $17,105 - $19,989	-3,277 Reduced 5.01%	62,139 $353,000
Q1 2019 May 01, 2019	BUY	$5.66 - $7.89 $370,254 - $516,132	65,416 New	65,416 $393,000

Others Institutions Holding SIGA

# of Institutions

205

Shares Held

35.5M

Call Options Held

70.9K

Put Options Held

16.6K

Black Rock Inc. New York, NY

3.91M
Shares

$23.5 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

2.66M
Shares

$15.9 Million
0.0% of portfolio
Dimensional Fund Advisors LP Austin, TX

2.43M
Shares

$14.6 Million
0.0% of portfolio
Altra Vue Capital, LLC Bellevue, WA

2.42M
Shares

$14.5 Million
2.09% of portfolio
American Century Companies Inc Kansas City, MO

1.23M
Shares

$7.4 Million
0.01% of portfolio

View Full List

About SIGA TECHNOLOGIES INC

Ticker SIGA
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 73,024,096
Market Cap $438M
Description
SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security and infectious disease markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc. has a strategic partnership with Cipla T...

More about SIGA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Alps Advisors Inc with notifications on news.

Account